Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: a systematic review and meta-analysis

• Van Doorn R.
• Mukhtarova N.
• Flyke I.P.
• Lasarev M.
• Kim К.
• Hennekens Ch.H.
• Hoppe K.K.

Abstract

Aim. To evaluate the effect of aspirin dose on the incidence of all gestational age preeclampsia and preterm preeclampsia.

Data sources. Electronic databases (Cochrane, PubMed, Scopus, ClinicalTrials.gov and the Web of Science) were searched for articles published between January 1985 and March 2019 with no language restrictions.

Methods. We followed the PRIMSA guidelines and utilized Covidence software. Articles were screened by 2 independent reviewers, with discrepancies settled by an independent 3^rd party. Study selection criteria were randomized trials comparing aspirin for prevention of all gestational age and preterm preeclampsia to placebo or no antiplatelet treatment in women aged 15-55 years with moderate or high-risk factors according to the list of risk factors from American College of Obstetricians and Gynecologists and United States Preventive Services Task Force guidelines. The quality of trials was assessed using the Cochrane risk of bias tool. The data were pooled using a random-effects meta-analysis comparing aspirin at doses of <81, 81, 100, and 150 mg. Prespecified outcomes were all gestational age and preterm preeclampsia.

Results. Of 1609 articles screened, 23 randomized trials, which included 32,370 women, fulfilled the inclusion criteria. In preterm preeclampsia, women assigned at random to 150 mg experienced a significant 62% reduction in risk of preterm preeclampsia (RR=0.38; 95% CI: 0.20-0.72; р=0.011). Aspirin doses <150 mg produced no significant reductions. The number needed to treat with 150 mg of aspirin was 39 (95% CI: 23-100). There was a maximum 30% reduction in risk of all gestational age preeclampsia at all aspirin doses.

Conclusion. In this meta-analysis, based on indirect comparisons, aspirin at a dose greater than the current, recommended 81 mg was associated with the highest reduction in preterm preeclampsia. Our meta-analysis is

Limited due to the deficiency of homogeneous high evidence data available in the Literature to date; however, it may be prudent for clinicians to consider that the optimal aspirin dose may be higher than the current guidelines advise. Future research to compare the efficacy aspirin doses greater than 81 mg is recommended.

Study registration. PROSPERO, CRD42019127951 (University of York, UK; http://www.crd.york.ac.uk/PROSPERO/).

References

1. Lo J.O., Mission J.F., Caughey A.B. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol. 2013; 25: 124–32. Epub 2013 Apr 25. DOI: https://doi.org/10.1097/GCO.0b013e32835e0ef5 PMID: 23403779.

2. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009; 33 (3): 130–7. DOI: https://doi.org/10.1053/j.semperi.2009.02.010 PMID: 19464502.

3. ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019; 133 ( 1): 1. URL: www.acog.org/Womens-Health/Preeclampsia-and-Hypertension-in-Pregnancy?IsMobileSet=false#Providers

4. Force USPST. Final Update Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality from Pree clampsia: Preventive Medication U.S. Preventative Services Task Force. 2016. URL: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-frompreeclampsia-preventive-medication

5. Ro lnik D.L., Wright D., Poon L.C., O’Gorman N., Syngelaki A., de Paco Matallana C., et al. Aspirin versus placebo in pregn ancies at high risk for

preterm preeclampsia. N Engl J Med. 2017; 377 (7): 613–22. DOI: https://doi.org/10.1056/NEJMoa1704559 PMID: 28657417

6. Cui Y.C., Zhu B., Zheng F. Low-dose aspirin at < = 16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: a systematic review and meta-analysis. Exp Ther Med. 2018; 15 (5): 4361–9. DOI: https://doi.org/10.3892/etm.2018.5972 PMID: 29725376

7. Beaufils M., Uzan S., Donsimoni R., Colau J.C. Prevention of preeclampsia by early antiplatelet therapy. Lancet. 1985; 1 (8433): 840–2. Epub 1985 Apr 4. DOI: https://doi.org/10.1016/s0140-6736(85)92207-x PMID: 2858710.

8. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetr. J Clin Epidemiol. 2008; 61 (10): 991- 6. Epub 2000 Oct 6. DOI: https://doi.org/10.1016/j.jclinepi.2007.11.010 PMID: 18538991.

9. Harris R., Bradburn M., Deeks J., Harbord R., Altman D., Sterne J. Metan: fixed-and random-effects meta-analysis. Stata J. 2008; 8 (1): 3-28.

10. Harbord R.M., Harris R.J., Sterne J.A.C. Updated tests for small-study effects in meta-analyses. Stata J. 2009; 9 (2): 197-210.

11. Palmer T.M., Peters J.L., Sutton A.J., Moreno S.G. Contour-enhanced funnel plots for meta-analysis. Stata J. 2008; 8 (2): 242-54.

12. Atallah A., Lecarpentier E., Goffinet F., Doret-Dion M., Gaucherand P., Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs. 2017; 77 (17): 1819-31. Epub 2017 Oct 19. DOI: https://doi.org/10.1007/s40265-017-0823-0 PMID: 29039130; PubMed Central PMCID: PMC5681618.

13. Roberge S., Nicolaides K., Demers S., Hyett J., Chaillet N., Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 216 (2): 110-20.e6. Epub 2016 Sept 20. DOI: https://doi.org/10.1016/j.ajog.2016.09.076 PMID: 27640943.

14. Cui Y., Zhu B., Zheng F. Low-dose aspirin at <16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: a systematic review and meta-analysis. Exp Ther Med. 2018; 15: 4361-9. DOI: https://doi.org/10.3892/etm.2018.5972 PMID: 29725376.

15. Werner E.F., Hauspurg A.K., Rouse D.J. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol. 2015; 126 (6): 1242-50. DOI: https://doi.org/10.1097/AOG.0000000000001115 PMID: 26551178.

16. Mirabito Colafella K.M., Neuman R.I., Visser W., Danser A.H.J., Versmissen J. Aspirin for the prevention and treatment of pre-eclampsia: a matter of COX-1 and/or COX-2 inhibition? Basic Clin Pharmacol Toxicol. 2020; 127 (2): 132-41. Epub 2019 Aug 20. DOI: https://doi.org/10.im/bcpt.13308 PMID: 31420920.

17. Ayala D.E., Ucieda R., Hermida R.C. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013; 30 (1-2): 260-79. DOI: https://doi.org/10.3109/07420528.2012.717 455 PMID: 23004922.

18. Beroyz G., Casale R., Farreiros A., Palermo M., Margulies M., Voto L. , et al. CLASP - a randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant-women. Lancet. 1994; 343 (8898): 619-29. PMID: 7906809

19. Byaruhanga R.N., Chipato T., Rusakaniko S. A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. Int J Gynecol Obstet. 1998; 60 (2): 129-35. DOI: https://doi.org/10.1016/s0020-7292(97)00257-9 PMID: 9509950.

20. Caspi E., Raziel A., Sherman D., Arieli S., Bukovski I., Weinraub Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin - a preliminary report. Am J Reprod Immunol. 1994; 31 (1): 19-24. DOI: https://doi.org/10.111Vj.1600-0897.1994.tb00842.x PMID: 8166943.

21. Chiaffarino F., Parazzini F., Paladini D., Acaia B., Ossola W., Ma-rozio L., et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2004; 112 (2): 142-4. DOI: https://doi.org/10.1016/s0301-2115(03)00269-0 PMID: 14746947.

22. Ebrashy A., Ibrahim M., Marzook A., Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J. 2005; 46 (5): 826-31. PMID: 16158479.

23. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol. 1996; 103 (1): 39-47.

24. Gilani A., Khan Z. Role of aspirin in management of pregnancy induced hypertension. A study in Pakistani population. Specialist. 1994; 10 (4): 323-5.

25. Golding J., Forrester T., Jones D., McCaw-Binns A., Palmer-Levy M., Wilks R., et al. A randomised trial of low dose aspirin for primiparae in pregnancy. Br J Obstet Gynaecol. 1998; 105 (3): 293-9. DOI: https://doi.org/10.1111/j.1471-0528.1998.tb10089.x PMID: 9532989.

26. Haapsamo M., Martikainen H., Tinkanen H., Heinonen S., Nuojua-Huttunen S., Rasanen J. Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. Hum Reprod. 2010; 25 (12): 2972-7. DOI: https://doi.org/10.1093/humrep/deq286 PMID: 20943705.

27. Hauth J., Goldenberg R., Philips J., Copper R., DuBard M,. Cutter G. Low-dose aspirin therapy to prevent preeclampsia: safety considerations. Am J Obstet Gynecol. 1993; 168: 389.

28. Herabutya Y., Jetsawangsri T., Saropala N. The use of low-dose aspirin to prevent preeclampsia. Int J Gynaecol Obstet. 1996; 54 (2): 177-8. DOI: https://doi.org/10.1016/0020-7292(96)02701-4 PMID: 9236320.

29. Morris J.M., Fay R.A., Ellwood D.A., Cook C.M., Devonald K.J. A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol. 1996; 87 (1): 74-8. Epub 1996 Jan 1. DOI: https://doi.org/10.1016/0029-7844(95)00340-1 PMID: 8532271.

30. Odibo A.O., Goetzinger K.R., Odibo L., Tuuli M.G. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2015; 46 (4): 414-8. DOI: https://doi.org/10.1002/uog.14889 PMID: 25914193.

31. Parazzini F. , Benedetto C., Frusca T., Gregorini G., Bocciolone L., Marozio L., et al. Low-dose aspirin in prevention and treatment of intrauterine growth-retardation and pregnancy-induced hypertension. Lancet. 1993; 341 (8842): 396-400. PMID: 8094168

32. Rolnik D.L., Wright D., Poon L.C.Y., Syngelaki A., O'Gorman N., de Paco Matallana C., et al. ASPRE trial: performance of screening for preterm preeclampsia. Ultrasound Obstet Gynecol. 2017; 50 (4): 492-5. Epub 2017 Jul 26. DOI: https://doi.org/10.1002/uog.18816 PMID: 28741785.

33. Rotchell Y.E . , Cruickshank J.K., Gay M.P., Griffiths J., Stewart A., Farrell B., et al. Barbados low dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol. 1998; 105 (3): 286-92. DOI: https://doi.org/10.1111/j.1471-0528.1998.tb10088.x PMID: 9532988.

34. Subtil D., Goeusse P., Puech F., Lequien P., Biausque S., Breart G., et al. Aspirin (100 mg) used for prevention of pre-eclampsia in nullipa-rous women: the Essai Regional Aspirine Mere-Enfant study (part 1). BJOG. 2003; 110: 475-84.

35. Talari H., Mesdaghinia E., Abedzadeh Kalahroudi M. Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow. Iran Red Crescent Med J. 2014; 16 (8): e17175. DOI: https://doi.org/10.5812/ircmj.17175 PMID: 25389483; PMCID: PMC4222009.

36. Tewari S., Kaushish R., Sharma S., Gulati N. Role of low dose aspirin in prevention of pregnancy induced hypertension. J Indian Med Assoc. 1997; 95 (2): 43-4. PMID: 9357241.

37. Vainio M., Kujansuu E., Iso-Mustajarvi M., Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG. 2002; 109 (2): 161-7. DOI: https://doi.org/10.1111/j.1471-0528.2002.01046.x PMID: 11888098.

38. Viinikka L., Hartikainen-Sorri A.L., Lumme R., Hiilesmaa V., Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol. 1993; 100 (9): 809-15. DOIL https://doi.org/10.1111/j.1471-0528.1993.tb14304.x PMID: 8217999.

39. Villa P.M., Kajantie E., Raikkonen K., Pesonen A.K., Hamalainen E., Vainio M., et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG. 2013; 120 (1): 64 - 74. DOI: https://doi.org/10.1111/j.1471-0528.2012.03493.x PMID: 23126307.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)